We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

A New EU-Funded Industry-Academia Drug Discovery Partnership Targets Challenging Kinases

News   Apr 10, 2013

 
A New EU-Funded Industry-Academia Drug Discovery Partnership Targets Challenging Kinases
 
 
 

RELATED ARTICLES

Test Which Identifies Drug-resistant Tuberculosis Bacteria Now Available In Europe

News

Now available in Europe: A diagnostic test which can simultaneously detect tuberculosis-causing bacteria and determine if the bacteria contain mutations associated with resistance to two important first line drugs.

READ MORE

Immune Therapy Shows Promise for Ankylosing Spondylitis

News

Patients who have not benefited from standard therapy for ankylosing spondylitis (AS), a chronic inflammatory disease characterized by back pain and sacroiliac-joint damage, may soon have another option.

READ MORE

Making Custom-designed Natural Products

News

Microorganisms often assemble natural products similar to industrial assembly lines. Certain enzymes, non-ribosomal peptide synthetases (NRPS) play a key role in this process. Biotechnologists have now discovered how these enzymes interact with each other, bringing them one step closer to their goal of engineering peptide natural products.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE